Sialic acid-containing ligand

Sialic acid-containing ligands are diverse glycoconjugates (glycoproteins, glycolipids, oligosaccharides) found predominantly on the outer surfaces of animal cell membranes, where terminal sialic acid residues cap glycan chains[1][2][3][4][5]. These ligands mediate cell-cell interactions, regulate immune responses, and act as key recognition elements for host and microbial lectin receptors, including Siglecs, selectins, and viral hemagglutinin[1][2][3][7][9]. Their display is critical for modulating self vs. non-self discrimination by the immune system, stabilizing glycoproteins, and representing major “address codes” for leukocyte trafficking and pathogen entry. Changes in sialylation or sialic acid composition are implicated in cancer, infection, immune escape, and neurodevelopmental disorders. Importantly, "sialic acid-containing ligand" is a structural/glycomic descriptor, not a specific molecular target or receptor, and thus is not a canonical drug target in the traditional sense[2]. In summary: - Not a classical receptor or defined single target. - Term refers to a molecular attribute (terminal sialic acid) on ligands for other bona fide receptors (e.g., Siglec, selectin). - Important in many physiological and pathological processes through glycan-mediated recognition. If a specific receptor or functional protein (such as "Siglec-7 receptor" or "selectin") is intended, structuring the query for that protein will allow for more precise, drug-targetable information.

Other names

SialoglycanSialoglycoconjugateSialosideSialylated ligandSialylated glycanSialylated glycoproteinSialylated glycolipid

Blocking binding of viruses/bacteria to host cells by interfering with sialic acid recognition Modulating immune receptor (e.g., Siglec, selectin) signaling by altering ligand sialylation Inhibiting sialyltransferases (prevents sialic acid addition to glycans) Inhibiting neuraminidases (prevents hydrolysis/removal of sialic acids)